The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Statin use and cancer risk: a comprehensive review
Open accessAbstract
IMPORTANCE OF THE FIELD: HMG-CoA inhibitors (statins), a class of drugs that reduce cholesterol, are used to manage and prevent coronary heart disease. They are among the most commonly prescribed drugs worldwide. Contrary to early concerns over the carcinogenicity of statins, a growing body of evidence suggests statins may in fact have a chemopreventive potential against cancer. AREAS COVERED IN THIS REVIEW: In this paper, we review evidence on the association between statin use and cancer risk. Specifically, we report on clinical trials and observational studies that measured all cancer or site-specific cancers of the breast, colorectal, lung, prostate and reproductive organs associated with statin use. WHAT THE READER WILL GAIN: An understanding of the evidence, including strengths and limitations, to support an association between statins and cancer. Information on the current state of the field and future directions are also discussed. TAKE HOME MESSAGE: Few strong or consistent associations between statins and cancer incidence overall or for any of the sites reviewed were detected. Data for any effects of statins on cancer prognosis and secondary prevention are lacking; with the exception of consistent evidence that statins are associated with reduced risk of advanced/aggressive prostate cancer. Statins appear safe in relation to cancer risk but any chemopreventive effect in humans remains to be established and should not be recommended outside the context of clinical trials. It is encouraging that numerous trials are ongoing. The prospect of reducing the incidence and burden of some of the most prevalent cancers with safe, affordable and tolerable medication that already reduces the risk of the leading cause of death and cardiovascular disease warrants further exploration in clinical trials and observational studies of prognosis and survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2998 · Cited by 1,331
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Statins and the Risk of Colorectal Cancer
Poynter, J. N., Gruber, S. B., Higgins, P. D. R., Almog, R., Bonner, J. D., Rennert, H. S., Low, M., Greenson, J. K., & Rennert, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043792 · Cited by 816
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
The statins as anticancer agents.
Chan, K., Oza, A. M., & Siu, L. L. (2003) · PubMed · Cited by 618
Statins and Cancer Risk: A Meta-analysis
Dale, K. M., Coleman, C. I., Henyan, N. N., Kluger, J., & White, C. M. (2006) · JAMA · doi:10.1001/jama.295.1.74 · Cited by 599
Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 578
The Risk of Cancer in Users of Statins
Graaf, M. R., Beiderbeck, A. B., Egberts, A. C. G., Richel, D. J., & Guchelaar, H.-J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.027 · Cited by 528
HEBERT, P. R., GAZIANO, J. M., CHAN, K. S., & HENNEKENS, C. H. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199806000-00060 · Cited by 506
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ford, I., Murray, H., Packard, C. J., Shepherd, J., Macfarlane, P. W., & Cobbe, S. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065994 · Cited by 416
Statin Drugs and Risk of Advanced Prostate Cancer
Platz, E. A., Leitzmann, M. F., Visvanathan, K., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj499 · Cited by 406
Brookhart, M. A., Patrick, A. R., Dormuth, C., Avorn, J., Shrank, W., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 381
Carcinogenicity of Lipid-Lowering Drugs
Newman, T. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530250059028 · Cited by 380
Smoking and Lung Cancer: The Role of Inflammation
Walser, T., Cui, X., Yanagawa, J., Lee, J. M., Heinrich, E., Lee, G., Sharma, S., & Dubinett, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-100th · Cited by 379
Schneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061250 · Cited by 366
Breast Cancer Growth Prevention by Statins
Campbell, M. J., Esserman, L. J., Zhou, Y., Shoemaker, M., Lobo, M., Borman, E., Baehner, F., Kumar, A. S., Adduci, K., Marx, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4061 · Cited by 348
Blais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326
Assessing possible hazards of reducing serum cholesterol
Law, M. R., Thompson, S. G., & Wald, N. J. (1994) · BMJ · doi:10.1136/bmj.308.6925.373 · Cited by 309
Statins and cancer: A systematic review and meta-analysis
Kuoppala, J., Lamminpää, A., & Pukkala, E. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.025 · Cited by 285
Cancer risk among statin users: A population‐based cohort study
Friis, S., Poulsen, A. H., Johnsen, S. P., McLaughlin, J. K., Fryzek, J. P., Dalton, S. O., Sørensen, H. T., & Olsen, J. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.20758 · Cited by 275
Statin use and cancer risk in the General Practice Research Database
Kaye, J. A., & Jick, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601566 · Cited by 248
Statin Adherence and Risk of Accidents: A Cautionary Tale
Dormuth, C. R., Patrick, A. R., Shrank, W. H., Wright, J. M., Glynn, R. J., Sutherland, J., & Brookhart, M. A. (2009) · Circulation · doi:10.1161/circulationaha.108.824151 · Cited by 244
Smeeth, L., Douglas, I., Hall, A. J., Hubbard, R., & Evans, S. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03308.x · Cited by 234
Bonovas, S., Filioussi, K., Tsavaris, N., & Sitaras, N. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7045 · Cited by 233
Statins and Prostate Cancer Risk: A Case-Control Study
Shannon, J., Tewoderos, S., Garzotto, M., Beer, T. M., Derenick, R., Palma, A., & Farris, P. E. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi203 · Cited by 232
Statins Reduce the Risk of Lung Cancer in Humans
Khurana, V., Bejjanki, H. R., Caldito, G., & Owens, M. W. (2007) · Chest · doi:10.1378/chest.06-0931 · Cited by 230
Statins and risk of cancer: A systematic review and metaanalysis
Browning, D. R. L., & Martin, R. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22366 · Cited by 228
Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients
Friedman, G. D., Flick, E. D., Udaltsova, N., Chan Pharm D, J., Quesenberry, C. P., & Habel, L. A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1507 · Cited by 221
Kusama, T., Mukai, M., Iwasaki, T., Tatsuta, M., Matsumoto, Y., Akedo, H., & Nakamura, H. (2001) · PubMed · Cited by 210
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
Ahn, J., Lim, U., Weinstein, S. J., Schatzkin, A., Hayes, R. B., Virtamo, J., & Albanes, D. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1248 · Cited by 207
The Association Between Statins and Cancer Incidence in a Veterans Population
Farwell, W. R., Scranton, R. E., Lawler, E. V., Lew, R. A., Brophy, M. T., Fiore, L. D., & Gaziano, J. M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm286 · Cited by 197
Do statins cause cancer? A meta-analysis of large randomized clinical trials
Bjerre, L. M., & LeLorier, J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00705-7 · Cited by 195
Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study
Murtola, T. J., Tammela, T. L. J., Lahtela, J., & Auvinen, A. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0599 · Cited by 191
Statin Use and Breast Cancer: Prospective Results From the Women's Health Initiative
Cauley, J. A., McTiernan, A., Rodabough, R. J., LaCroix, A., Bauer, D. C., Margolis, K. L., Paskett, E. D., Vitolins, M. Z., Furberg, C. D., & Chlebowski, R. T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj188 · Cited by 179
Kwan, M. L., Habel, L. A., Flick, E. D., Quesenberry, C. P., & Caan, B. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9683-8 · Cited by 175 · cited 1×
“Similar promising results were presented for decreased risk of breast cancer recurrence with statin use [55].”
ResultBonovas, S., Filioussi, K., Tsavaris, N., & Sitaras, N. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3560 · Cited by 172
Statin Use and the Risk of 10 Cancers
Coogan, P. F., Rosenberg, L., & Strom, B. L. (2007) · Epidemiology · doi:10.1097/01.ede.0000254694.03027.a1 · Cited by 162
The Influence of Statin Medications on Prostate-specific Antigen Levels
Hamilton, R. J., Goldberg, K. C., Platz, E. A., & Freedland, S. J. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn362 · Cited by 162
Incidence of cancer and statin usage—Record linkage study
Haukka, J., Sankila, R., Klaukka, T., Lonnqvist, J., Niskanen, L., Tanskanen, A., Wahlbeck, K., & Tiihonen, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24536 · Cited by 160
Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic Study
Agalliu, I., Salinas, C. A., Hansten, P. D., Ostrander, E. A., & Stanford, J. L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn141 · Cited by 159
Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly
Setoguchi, S., Glynn, R. J., Avorn, J., Mogun, H., & Schneeweiss, S. (2007) · Circulation · doi:10.1161/circulationaha.106.650176 · Cited by 158
Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study
Cauley, J. A., Zmuda, J. M., Lui, L., Hillier, T. A., Ness, R. B., Stone, K. L., Cummings, S. R., & Bauer, D. C. (2003) · Journal of Women s Health · doi:10.1089/154099903322447710 · Cited by 154
Cholesterol-Lowering Drugs and Advanced Prostate Cancer Incidence in a Large U.S. Cohort
Jacobs, E. J., Rodriguez, C., Bain, E. B., Wang, Y., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0448 · Cited by 152
Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort
Flick, E. D., Habel, L. A., Chan, K. A., Eeden, S. K. V. D., Quinn, V. P., Haque, R., Orav, E. J., Seeger, J. D., Sadler, M. C., Quesenberry, C. P., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0197 · Cited by 152
Karp, I., Behlouli, H., LeLorier, J., & Pilote, L. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.12.011 · Cited by 151
Bonovas, S., Filioussi, K., & Sitaras, N. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23550 · Cited by 149
Serum Cholesterol and Cancer Risk: An Epidemiologic Persepective
Kritchevsky, S. B., & Kritchevsky, D. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.002135 · Cited by 146
Bonovas, S., Filioussi, K., Flordellis, C. S., & Sitaras, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8936 · Cited by 141
Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas
Huls, G. A., Koornstra, J. J., & KLEIBEUKER, J. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13915-3 · Cited by 140
Statin Use and the Risk of Breast and Prostate Cancer
Coogan, P. F., Rosenberg, L. A., Palmer, J. R., Strom, B. L., Zauber, A. G., & Shapiro, S. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00005 · Cited by 137
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin
Wong, W. W.-L., Tan, M. M., Xia, Z., Dimitroualakos, J., Minden, M. D., & Penn, L. Z. (2001) · PubMed · doi:10.5167/uzh-58181 · Cited by 129
Sivaprasad, U., Abbas, T., & Dutta, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0175 · Cited by 127
Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
Eliassen, A. H., Colditz, G. A., ROSNER, B. A., Willett, W. C., & Hankinson, S. E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.19.2264 · Cited by 125
Boudreau, D. M., Gardner, J. S., Malone, K. E., Heckbert, S. R., Blough, D. K., & Daling, J. R. (2004) · Cancer · doi:10.1002/cncr.20271 · Cited by 123
Self-citationWächtershäuser, A., Akoglu, B., & Stein, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1061 · Cited by 123
Statin Use and Risk of Colorectal Cancer
Coogan, P. F., Smith, J., & Rosenberg, L. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk003 · Cited by 122
Denoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 120
Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
Alsheikh-Ali, A. A. A., Trikalinos, T. A., Kent, D. M., & Karas, R. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.037 · Cited by 114
Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
Murtola, T. J., Tammela, T. L. J., Määttänen, L., Huhtala, H., Platz, E. A., Ala‐Opas, M., Stenman, U., & Auvinen, A. P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25165 · Cited by 105
Statins and cancer: a meta-analysis of case–control studies
Taylor, M. L., Wells, B. J., & Smolak, M. J. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282b721fe · Cited by 103
Statin use and the risk of breast cancer
Beck, P., Wysowski, D. K., Downey, W., & Butler-Jones, D. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00614-5 · Cited by 97
Statins Can Inhibit Proliferation of Human Breast Cancer Cells in Vitro
Seeger, H., Wallwiener, D. R., & Mueck, A. O. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-37501 · Cited by 96
Statin use, hyperlipidaemia, and the risk of breast cancer
Kaye, J. A., Meier, C. R., Walker, A. M., & Jick, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600267 · Cited by 95
Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
Xiao, H., & Yang, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23718 · Cited by 92
Cholesterol-Lowering Drugs and Colorectal Cancer Incidence in a Large United States Cohort
Jacobs, E. J., Rodriguez, C., Brady, K. A., Connell, C. J., Thun, M. J., & Calle, E. E. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj006 · Cited by 92
Vinogradova, Y., Hippisley‐Cox, J., Coupland, C. A. C., & Logan, R. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.023 · Cited by 91
Statins and Cancer Development
Duncan, R. E., El‐Sohemy, A., & Archer, M. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0027 · Cited by 90
Statin Use and Breast Cancer Risk in a Large Population-Based Setting
Boudreau, D. M., Yu, O., Miglioretti, D. L., Buist, D. S. M., Heckbert, S. R., & Daling, J. R. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0737 · Cited by 87
Self-citationInhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin
Hawk, M. A., Cesen, K. T., Siglin, J. C., Stoner, G. D., & Ruch, R. J. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04465-5 · Cited by 87
Cyrus‐David, M. S., Weinberg, A. D., Thompson, T. C., & Kadmon, D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000158044.94188.88 · Cited by 83
Hoffmeister, M., Chang-Claude, J. C., & Brenner, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22796 · Cited by 80
Moyad, M. A., Merrick, G. S., Butler, W. M., Wallner, K. E., Galbreath, R. W., Kurko, B. S., & Adamovich, E. (2005) · Urology · doi:10.1016/j.urology.2005.08.053 · Cited by 75
Long-Term Use of Statins and Risk of Colorectal Cancer: A Population-Based Study
Singh, H., Mahmud, S. M., Turner, D., Xue, L., Demers, A. A., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.574 · Cited by 71
Statin use and prostate cancer risk in a large population-based setting
Boudreau, D. M., Yu, O., Buist, D. S. M., & Miglioretti, D. L. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9139-4 · Cited by 65
Self-citationCardiovascular Medication Use and Risk for Colorectal Cancer
Boudreau, D. M., Koehler, E., Rulyak, S. J., Haneuse, S., Harrison, R., & Mandelson, M. T. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0095 · Cited by 57
Self-citationChronic statin therapy and the risk of colorectal cancer
Yang, Y., Hennessy, S., PROPERT, K. J., Hwang, W., Sarkar, M., & Lewis, J. D. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1599 · Cited by 55
Krane, L. S., KAUL, S. A., Stricker, H. J., Peabody, J. O., Menon, M., & Agarwal, P. K. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.151 · Cited by 47
Statin use and female reproductive organ cancer risk in a large population-based setting
Yu, O., Boudreau, D. M., Buist, D. S. M., & Miglioretti, D. L. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9271-1 · Cited by 47
Self-citationIs statin use associated with prostate cancer aggressiveness?
Loeb, S., Kan, D., Helfand, B. T., Nadler, R. B., & Catàlona, W. J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09007.x · Cited by 42
Mondul, A. M., Selvin, E., Marzo, A. M. D., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9494-9 · Cited by 41
Statins to reduce breast cancer risk: A case control study in U.S. female veterans
Kochhar, R., Khurana, V., Bejjanki, H. R., Caldito, G. C., & Fort, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.514 · Cited by 41
Cholesterol and Cancer: Answers and New Questions
Jacobs, E. J., & Gapstur, S. M. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1027 · Cited by 36
Chemoprevention of colorectal cancer: feasibility in everyday practice?
Herszényi, L., Farinati, F., Miheller, P., & Tulassay, Z. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f0c080 · Cited by 32
Lipid-Lowering Medication and Risk of Cancer
Olsen, J. H., Johansen, C., Sørensen, H. T., McLaughlin, J. K., Mellemkjær, L., Steffensen, F. H., & Fraumeni, J. F. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00147-4 · Cited by 31
Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk
Shadman, M. S., Newcomb, P. A., Hampton, J. M., Wernli, K. J., & Trentham‐Dietz, A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2336 · Cited by 30
Statins and Breast Cancer: May Matrix Metalloproteinase be the Missing Link
Mannello, F., & Tonti, G. A. (2009) · Cancer Investigation · doi:10.1080/07357900802491444 · Cited by 30
Statins and prostate cancer risk: A large case control study in veterans
Singal, R., Khurana, V., Caldito, G. C., & Fort, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.1004 · Cited by 24
Epidemiologic Musing on Statin Drugs in the Prevention of Advanced Prostate Cancer
Platz, E. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0777 · Cited by 23
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Statin Use and Reduced Cancer-Related Mortality
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 720
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Metadata
- Authors
- Boudreau, D. M., Yu, O., & Johnson, J.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2010-04-09
- Volume
- 9
- Issue
- 4
- Pages
- 603-621
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2072073513
- Cited by
- 274
- References
- 102
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.